X0206 3 2021-02-03 0 0001770121 Sana Biotechnology, Inc. SANA 0001616640 AGARWAL SUNIL C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 0 1 0 0 See Remarks Common Stock 1610000 D Stock Option (Right to Buy) 1.44 2029-07-14 Common Stock 75000 D Stock Option (Right to Buy) 1.48 2030-01-26 Common Stock 125000 D The option vests and becomes exercisable as to 1/48th of the underlying shares in equal monthly installments with the first of such installment on August 15, 2019. The option vests and becomes exercisable as to 25% of the underlying shares on February 14, 2021 and in 36 equal monthly installments thereafter. EVP, Head of Development and Chief Medical Officer Exhibit 24 - Power of Attorney. /s/ James J. MacDonald, Attorney-in-Fact for Sunil Agarwal 2021-02-03